NEXT Oncology Partners with Spanish Hospital System to Open Two Phase I Clinical Centers

 New venture marks third and fourth site expansion in five months  (SAN ANTONIO) November 18, 2021 –– NEXT Oncology, founded by internationally known cancer researcher Dr. Anthony Tolcher, has entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain. The venture increases global access to new agents and anticancer therapies for …

Medical World News® Inside the Practice: CancerNetwork® With Anthony W. Tolcher, MD, and Alexander I. Spira, MD, PhD, on Expand Access to Phase 1 Cancer Trials

For the latest installment of the Inside the Practice Segment of the Medical World News® broadcast, CancerNetwork® spoke with Anthony W. Tolcher, MD, co-founder of NEXT Oncology and a mMedical oOncologist at Texas Oncology, as well as Alexander I. Spira, MD, PhD, Medical Oncologist and dDirector of Virginia Cancer Specialists Research Institute and the Phase I Trial Program, to discuss their new …

Next Oncology Logo

Phase I Clinical Trials – A Necessity in the Advancement of Cancer Therapies

Dr. Anthony Tolcher, medical oncologist and co-founder of NEXT Oncology has said, “We are going to make cancer treatable or curable in my lifetime.” For that to happen, scientists, physicians and patients must come together to develop and test the latest anti-cancer therapies. And this begins with Phase I oncology clinical trials. What are Clinical Trials? Clinical trials are the …